/

Investors / Israel / NGT Healthcare II

NGT Healthcare II

Venture capital · Nazareth, Israel · Middle East and Africa

ngt-healthcare2.comTakes pitches from founders

NGT Healthcare II is an early-stage medical device and life sciences venture capital fund that invests in promising technologies. It is structured as an impact fund located in Nazareth, aligned with three UN SDGs, and uses non-dilutive leverage via Israel's Innovation Authority.

Invests inHealthcare & Biotech

In its own wordsmedical deviceslife scienceshealthcareimpactisrael

Your fit with NGT Healthcare II

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
21portfolio companies
0funding rounds on record
Seedstages it states

NGT Healthcare II lists 21 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (90%), E-commerce & Marketplaces (5%) and Fintech (5%). 67% of its companies are based in Israel. It invests most often alongside 3D Innotech, Auxxo and Auxxo Female Catalyst Fund.

No funding round on record names NGT Healthcare II yet, so the figures come from its portfolio page.

Round figures show recent activity, not NGT Healthcare II's whole history. Rounds on record name 0 companies; its own site lists 21. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Investor profile

percentile among all firms
Portfolio size: 21 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 90% in its largest sectorReach: 3 countriesPortfolio size53th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus95th pctReach58th pct
This firmMedian of all firms
Show as a table
NGT Healthcare II compared with all firms
MeasurePercentile of all firmsValue
Portfolio size53th21 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus95th90% in its largest sector
Reach58th3 countries

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers2095%
  • No longer answers00%
  • Points to another company15%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech90%15%
E-commerce & Marketplaces5%5%
Fintech5%12%

Compare NGT Healthcare II head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

21 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Ark Surgicalark-surgical.com · IsraelArk Surgical develops and markets a containment system for safer laparoscopic GYN surgeries.
Healthcare & Biotech
Portfolio page
Barcode Nanobarcode-nano.com · IsraelBarcode Nanotech is developing selective delivery vehicles for RNA/DNA-based drugs
Healthcare & Biotech
Portfolio page
CardioViacardiovia.com · United StatesCardioVia develops and markets the ViaOne epicardial access device to create a stable pathway to the heart's surface
Healthcare & Biotech
Portfolio page
Crocevia Medicalcroceviamedical.com · Israel
Healthcare & Biotech
Portfolio page
Cuspa Medicalcuspamedical.comCuspa Medical develops a transcatheter aortic valve repair device for treating aortic regurgitation
Healthcare & Biotech
Portfolio page
DioTreedio-tree.com · IsraelDioTree is developing first-in-class small-molecule inhibitors of DIO3 for cancer treatment
Healthcare & Biotech
Portfolio page
Elgan Pharmaelganpharma.comElgan Pharma is a late-stage neonatology-focused biotech company, dedicated to developing therapies for preterm infants.
Healthcare & Biotech
Portfolio page
Endo Giendo-gi.com
Portfolio page
HEPACURE-PHARMAhepacure-pharma.comHepacure Pharma is developing a first-in-class, dual-acting peptide therapy designed to address two biological drivers of liver fibrosis in MASH.
Healthcare & Biotech
Portfolio page
Intragelintra-gel.com · IsraelIntragel is developing the SRGel long-acting injectable platform for small molecules, peptides and biologics
Healthcare & Biotech
Portfolio page
Kailokailomedical.comKailo provides radiology workflow and reporting software solutions
Healthcare & Biotech
Portfolio page
MicroSteermicrosteer.com · IsraelMicroSteer develops medical devices for precise GI lesion resection
Healthcare & Biotech
Portfolio page
Neoflowneoflow.energy · United StatesNeoflow helps oil and gas companies prove origin, custody, and compliance using verifiable credentials built for modern customs and supply-chain workflows.
E-commerce & MarketplacesFintech
Portfolio page
ninamed.comninamed.com · IsraelNINA Medical develops a non-invasive treatment for an enlarged prostate using image-guided ultrasound
Healthcare & Biotech
Portfolio page
Noxonnoxon.io · GermanyNoxon develops a muscle-computer interface that orchestrates movement by translating brain-to-muscle signals into code
Healthcare & Biotech
Portfolio page
Nuraminurami-medical.comNurami harnesses nanofibers and novel biomaterials to modernize soft tissue surgical repair.
Healthcare & Biotech
Portfolio page
Parasonicpara-sonic.com
Portfolio page
Paragate Medicalparagate-medical.com · IsraelParagate Medical is developing an implantable device for the treatment of fluid overload in patients suffering from chronic heart or kidney failure.
Healthcare & Biotech
Portfolio page
Plas-Freeplas-free.comPlas-Free develops and produces medical devices to remove fibrinolytic factors and ammonia from blood products.
Healthcare & Biotech
Portfolio page
Virilityvirilitymedical.com · United StatesVirility Medical develops a wearable solution for premature ejaculation.
Healthcare & Biotech
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of NGT Healthcare II, as last read
ngt-healthcare2.com as VCinfo last read it
Site
ngt-healthcare2.com
Last read
5 Nov 2026
Watching since
6 Nov 2026
Companies checked
21

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get NGT Healthcare II's profile as data

Pull NGT Healthcare II's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/ngt-healthcare2.com

# also
GET /v1/firms/ngt-healthcare2.com/portfolio
GET /v1/firms/ngt-healthcare2.com/coinvestors
GET /v1/firms/ngt-healthcare2.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing